Cargando…

Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking

BACKGROUND: In Parkinson’s disease (PD), the effects of dopaminergic medication on straight walking and turning were mainly investigated under single tasking (ST) conditions. However, multitasking situations are considered more daily relevant. METHODS: Thirty-nine early-to-moderate PD patients perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshehabi, Morad, Maier, Katrin S., Hasmann, Sandra E., Nussbaum, Susanne, Herbst, Heinz, Heger, Tanja, Berg, Daniela, Hobert, Markus A., Maetzler, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728201/
https://www.ncbi.nlm.nih.gov/pubmed/26858638
http://dx.doi.org/10.3389/fnagi.2016.00004
_version_ 1782412076725043200
author Elshehabi, Morad
Maier, Katrin S.
Hasmann, Sandra E.
Nussbaum, Susanne
Herbst, Heinz
Heger, Tanja
Berg, Daniela
Hobert, Markus A.
Maetzler, Walter
author_facet Elshehabi, Morad
Maier, Katrin S.
Hasmann, Sandra E.
Nussbaum, Susanne
Herbst, Heinz
Heger, Tanja
Berg, Daniela
Hobert, Markus A.
Maetzler, Walter
author_sort Elshehabi, Morad
collection PubMed
description BACKGROUND: In Parkinson’s disease (PD), the effects of dopaminergic medication on straight walking and turning were mainly investigated under single tasking (ST) conditions. However, multitasking situations are considered more daily relevant. METHODS: Thirty-nine early-to-moderate PD patients performed the following standardized ST and dual tasks as fast as possible for 1 min during On- and Off-medication while wearing inertial sensors: straight walking and turning, checking boxes, and subtracting serial 7s. Quantitative gait parameters as well as velocity of the secondary tasks were analyzed. RESULTS: The following parameters improved significantly in On-medication during ST: gait velocity during straight walking (p = 0.03); step duration (p = 0.048) and peak velocity (p = 0.04) during turning; velocity of checking boxes during ST (p = 0.04) and DT (p = 0.04). Velocity of checking boxes was the only parameter that also improved during DT. CONCLUSION: These results suggest that dopaminergic medication does not relevantly influence straight walking and turning in early-to-moderate PD during DT.
format Online
Article
Text
id pubmed-4728201
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-47282012016-02-08 Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking Elshehabi, Morad Maier, Katrin S. Hasmann, Sandra E. Nussbaum, Susanne Herbst, Heinz Heger, Tanja Berg, Daniela Hobert, Markus A. Maetzler, Walter Front Aging Neurosci Neuroscience BACKGROUND: In Parkinson’s disease (PD), the effects of dopaminergic medication on straight walking and turning were mainly investigated under single tasking (ST) conditions. However, multitasking situations are considered more daily relevant. METHODS: Thirty-nine early-to-moderate PD patients performed the following standardized ST and dual tasks as fast as possible for 1 min during On- and Off-medication while wearing inertial sensors: straight walking and turning, checking boxes, and subtracting serial 7s. Quantitative gait parameters as well as velocity of the secondary tasks were analyzed. RESULTS: The following parameters improved significantly in On-medication during ST: gait velocity during straight walking (p = 0.03); step duration (p = 0.048) and peak velocity (p = 0.04) during turning; velocity of checking boxes during ST (p = 0.04) and DT (p = 0.04). Velocity of checking boxes was the only parameter that also improved during DT. CONCLUSION: These results suggest that dopaminergic medication does not relevantly influence straight walking and turning in early-to-moderate PD during DT. Frontiers Media S.A. 2016-01-27 /pmc/articles/PMC4728201/ /pubmed/26858638 http://dx.doi.org/10.3389/fnagi.2016.00004 Text en Copyright © 2016 Elshehabi, Maier, Hasmann, Nussbaum, Herbst, Heger, Berg, Hobert and Maetzler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Elshehabi, Morad
Maier, Katrin S.
Hasmann, Sandra E.
Nussbaum, Susanne
Herbst, Heinz
Heger, Tanja
Berg, Daniela
Hobert, Markus A.
Maetzler, Walter
Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
title Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
title_full Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
title_fullStr Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
title_full_unstemmed Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
title_short Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
title_sort limited effect of dopaminergic medication on straight walking and turning in early-to-moderate parkinson’s disease during single and dual tasking
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728201/
https://www.ncbi.nlm.nih.gov/pubmed/26858638
http://dx.doi.org/10.3389/fnagi.2016.00004
work_keys_str_mv AT elshehabimorad limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT maierkatrins limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT hasmannsandrae limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT nussbaumsusanne limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT herbstheinz limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT hegertanja limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT bergdaniela limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT hobertmarkusa limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking
AT maetzlerwalter limitedeffectofdopaminergicmedicationonstraightwalkingandturninginearlytomoderateparkinsonsdiseaseduringsingleanddualtasking